Porcine pseudorabies is an acute infectious disease of pigs caused by Pseudorabies virus (PrV). The disease is fulminant in pigs. It can cause abortion of pregnant sows, stillbirth, infertility of boars, death of a large number of newborn piglets, difficulty in breathing of fattening pigs, and stagnant growth. It is one of the major infectious diseases that harm the global pig industry.

The global Pseudorabies Virus Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pseudorabies Virus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Pseudorabies Virus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Pseudorabies Virus Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Pseudorabies Virus Vaccine include Merck, Merial Limited, Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, Hipra, Anhui Divinity Biological Products, Wuhan Keqian Biological Co., Ltd., China Biotechnology Co., Ltd. and CHINA ANIMAL HUSBANDRY INDUSTRY, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

Report Covers:

This report presents an overview of global market for Pseudorabies Virus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Pseudorabies Virus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pseudorabies Virus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pseudorabies Virus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pseudorabies Virus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Pseudorabies Virus Vaccine sales, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Pseudorabies Virus Vaccine Market Report

Report Metric	Details
Report Name	Pseudorabies Virus Vaccine Market
Segment by Type	Inactivated Vaccine Naturally Deficient Attenuated Vaccine Genetic Engineering Vaccine
Segment by Application	Government Tender Market Sales
Segment by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, Hipra, Anhui Divinity Biological Products, Wuhan Keqian Biological Co., Ltd., China Biotechnology Co., Ltd., CHINA ANIMAL HUSBANDRY INDUSTRY, Sichuan Huashen, Haley, Tianbang, Dabei Nong, Harvey, Preh Bio, Jiangsu Nannong High-Tech Co., Guangxi Liyuan Biological Co., Ltd., Jilin Zhengye Bioengineering Group, Jilin Heyuan Biological Engineering Co., Ltd., Huapai Biological Engineering Group Co., Ltd., Beijing Xinde Weite Technology Co., Ltd., Beijing Veterinary Biopharmaceutical Factory, Qilu Animal Health Products Co., Ltd., Shanxi Longkel Bio-Pharmaceutical Co., Ltd., Yunnan Biopharmaceutical Co., Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd., Liaoning Yikang Biological Co., Ltd., Shanghui Huahong Biological Engineering Co., Ltd., Sichuan Hailinge Biological Pharmaceutical Co., Ltd., Guangdong Yongshun Biological Pharmaceutical Co., Ltd.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Pseudorabies Virus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Pseudorabies Virus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pseudorabies Virus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pseudorabies Virus Vaccine Market report?

Ans: The main players in the Pseudorabies Virus Vaccine Market are Boehringer Ingelheim Animal Health (USA) Co., Ltd., Zoetis, Hipra, Anhui Divinity Biological Products, Wuhan Keqian Biological Co., Ltd., China Biotechnology Co., Ltd., CHINA ANIMAL HUSBANDRY INDUSTRY, Sichuan Huashen, Haley, Tianbang, Dabei Nong, Harvey, Preh Bio, Jiangsu Nannong High-Tech Co., Guangxi Liyuan Biological Co., Ltd., Jilin Zhengye Bioengineering Group, Jilin Heyuan Biological Engineering Co., Ltd., Huapai Biological Engineering Group Co., Ltd., Beijing Xinde Weite Technology Co., Ltd., Beijing Veterinary Biopharmaceutical Factory, Qilu Animal Health Products Co., Ltd., Shanxi Longkel Bio-Pharmaceutical Co., Ltd., Yunnan Biopharmaceutical Co., Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd., Liaoning Yikang Biological Co., Ltd., Shanghui Huahong Biological Engineering Co., Ltd., Sichuan Hailinge Biological Pharmaceutical Co., Ltd., Guangdong Yongshun Biological Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Pseudorabies Virus Vaccine Market report?

Ans: The Applications covered in the Pseudorabies Virus Vaccine Market report are Government Tender, Market Sales

What are the Type segmentation covered in the Pseudorabies Virus Vaccine Market report?

Ans: The Types covered in the Pseudorabies Virus Vaccine Market report are Inactivated Vaccine, Naturally Deficient Attenuated Vaccine, Genetic Engineering Vaccine

1 Study Coverage

1.1 Pseudorabies Virus Vaccine Product Introduction

1.2 Market by Type

1.2.1 Global Pseudorabies Virus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Inactivated Vaccine

1.2.3 Naturally Deficient Attenuated Vaccine

1.2.4 Genetic Engineering Vaccine

1.3 Market by Application

1.3.1 Global Pseudorabies Virus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Government Tender

1.3.3 Market Sales

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts 2019-2030

2.2 Global Pseudorabies Virus Vaccine Revenue by Region

2.2.1 Global Pseudorabies Virus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

2.2.2 Global Pseudorabies Virus Vaccine Revenue by Region (2019-2024)

2.2.3 Global Pseudorabies Virus Vaccine Revenue by Region (2025-2030)

2.2.4 Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2019-2030)

2.3 Global Pseudorabies Virus Vaccine Sales Estimates and Forecasts 2019-2030

2.4 Global Pseudorabies Virus Vaccine Sales by Region

2.4.1 Global Pseudorabies Virus Vaccine Sales by Region: 2019 VS 2023 VS 2030

2.4.2 Global Pseudorabies Virus Vaccine Sales by Region (2019-2024)

2.4.3 Global Pseudorabies Virus Vaccine Sales by Region (2025-2030)

2.4.4 Global Pseudorabies Virus Vaccine Sales Market Share by Region (2019-2030)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Pseudorabies Virus Vaccine Sales by Manufacturers

3.1.1 Global Pseudorabies Virus Vaccine Sales by Manufacturers (2019-2024)

3.1.2 Global Pseudorabies Virus Vaccine Sales Market Share by Manufacturers (2019-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Pseudorabies Virus Vaccine in 2023

3.2 Global Pseudorabies Virus Vaccine Revenue by Manufacturers

3.2.1 Global Pseudorabies Virus Vaccine Revenue by Manufacturers (2019-2024)

3.2.2 Global Pseudorabies Virus Vaccine Revenue Market Share by Manufacturers (2019-2024)

3.2.3 Global Top 10 and Top 5 Companies by Pseudorabies Virus Vaccine Revenue in 2023

3.3 Global Key Players of Pseudorabies Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

3.4 Global Pseudorabies Virus Vaccine Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Pseudorabies Virus Vaccine, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Pseudorabies Virus Vaccine, Product Offered and Application

3.8 Global Key Manufacturers of Pseudorabies Virus Vaccine, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Pseudorabies Virus Vaccine Sales by Type

4.1.1 Global Pseudorabies Virus Vaccine Historical Sales by Type (2019-2024)

4.1.2 Global Pseudorabies Virus Vaccine Forecasted Sales by Type (2025-2030)

4.1.3 Global Pseudorabies Virus Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Pseudorabies Virus Vaccine Revenue by Type

4.2.1 Global Pseudorabies Virus Vaccine Historical Revenue by Type (2019-2024)

4.2.2 Global Pseudorabies Virus Vaccine Forecasted Revenue by Type (2025-2030)

4.2.3 Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Pseudorabies Virus Vaccine Price by Type

4.3.1 Global Pseudorabies Virus Vaccine Price by Type (2019-2024)

4.3.2 Global Pseudorabies Virus Vaccine Price Forecast by Type (2025-2030)

5 Market Size by Application

5.1 Global Pseudorabies Virus Vaccine Sales by Application

5.1.1 Global Pseudorabies Virus Vaccine Historical Sales by Application (2019-2024)

5.1.2 Global Pseudorabies Virus Vaccine Forecasted Sales by Application (2025-2030)

5.1.3 Global Pseudorabies Virus Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Pseudorabies Virus Vaccine Revenue by Application

5.2.1 Global Pseudorabies Virus Vaccine Historical Revenue by Application (2019-2024)

5.2.2 Global Pseudorabies Virus Vaccine Forecasted Revenue by Application (2025-2030)

5.2.3 Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Pseudorabies Virus Vaccine Price by Application

5.3.1 Global Pseudorabies Virus Vaccine Price by Application (2019-2024)

5.3.2 Global Pseudorabies Virus Vaccine Price Forecast by Application (2025-2030)

6 US & Canada

6.1 US & Canada Pseudorabies Virus Vaccine Market Size by Type

6.1.1 US & Canada Pseudorabies Virus Vaccine Sales by Type (2019-2030)

6.1.2 US & Canada Pseudorabies Virus Vaccine Revenue by Type (2019-2030)

6.2 US & Canada Pseudorabies Virus Vaccine Market Size by Application

6.2.1 US & Canada Pseudorabies Virus Vaccine Sales by Application (2019-2030)

6.2.2 US & Canada Pseudorabies Virus Vaccine Revenue by Application (2019-2030)

6.3 US & Canada Pseudorabies Virus Vaccine Market Size by Country

6.3.1 US & Canada Pseudorabies Virus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

6.3.2 US & Canada Pseudorabies Virus Vaccine Sales by Country (2019-2030)

6.3.3 US & Canada Pseudorabies Virus Vaccine Revenue by Country (2019-2030)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Pseudorabies Virus Vaccine Market Size by Type

7.1.1 Europe Pseudorabies Virus Vaccine Sales by Type (2019-2030)

7.1.2 Europe Pseudorabies Virus Vaccine Revenue by Type (2019-2030)

7.2 Europe Pseudorabies Virus Vaccine Market Size by Application

7.2.1 Europe Pseudorabies Virus Vaccine Sales by Application (2019-2030)

7.2.2 Europe Pseudorabies Virus Vaccine Revenue by Application (2019-2030)

7.3 Europe Pseudorabies Virus Vaccine Market Size by Country

7.3.1 Europe Pseudorabies Virus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 Europe Pseudorabies Virus Vaccine Sales by Country (2019-2030)

7.3.3 Europe Pseudorabies Virus Vaccine Revenue by Country (2019-2030)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Pseudorabies Virus Vaccine Market Size

8.1.1 China Pseudorabies Virus Vaccine Sales (2019-2030)

8.1.2 China Pseudorabies Virus Vaccine Revenue (2019-2030)

8.2 China Pseudorabies Virus Vaccine Market Size by Application

8.2.1 China Pseudorabies Virus Vaccine Sales by Application (2019-2030)

8.2.2 China Pseudorabies Virus Vaccine Revenue by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Pseudorabies Virus Vaccine Market Size by Type

9.1.1 Asia Pseudorabies Virus Vaccine Sales by Type (2019-2030)

9.1.2 Asia Pseudorabies Virus Vaccine Revenue by Type (2019-2030)

9.2 Asia Pseudorabies Virus Vaccine Market Size by Application

9.2.1 Asia Pseudorabies Virus Vaccine Sales by Application (2019-2030)

9.2.2 Asia Pseudorabies Virus Vaccine Revenue by Application (2019-2030)

9.3 Asia Pseudorabies Virus Vaccine Sales by Region

9.3.1 Asia Pseudorabies Virus Vaccine Revenue by Region: 2019 VS 2023 VS 2030

9.3.2 Asia Pseudorabies Virus Vaccine Revenue by Region (2019-2030)

9.3.3 Asia Pseudorabies Virus Vaccine Sales by Region (2019-2030)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Market Size by Type

10.1.1 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Type (2019-2030)

10.1.2 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Type (2019-2030)

10.2 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Market Size by Application

10.2.1 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Application (2019-2030)

10.2.2 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Application (2019-2030)

10.3 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Country

10.3.1 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Country: 2019 VS 2023 VS 2030

10.3.2 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Country (2019-2030)

10.3.3 Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Country (2019-2030)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Merck

11.1.1 Merck Company Information

11.1.2 Merck Overview

11.1.3 Merck Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.1.4 Merck Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Merck Recent Developments

11.2 Merial Limited

11.2.1 Merial Limited Company Information

11.2.2 Merial Limited Overview

11.2.3 Merial Limited Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.2.4 Merial Limited Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Merial Limited Recent Developments

11.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd.

11.3.1 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Company Information

11.3.2 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Overview

11.3.3 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.3.4 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Developments

11.4 Zoetis

11.4.1 Zoetis Company Information

11.4.2 Zoetis Overview

11.4.3 Zoetis Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.4.4 Zoetis Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Zoetis Recent Developments

11.5 Hipra

11.5.1 Hipra Company Information

11.5.2 Hipra Overview

11.5.3 Hipra Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.5.4 Hipra Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Hipra Recent Developments

11.6 Anhui Divinity Biological Products

11.6.1 Anhui Divinity Biological Products Company Information

11.6.2 Anhui Divinity Biological Products Overview

11.6.3 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.6.4 Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 Anhui Divinity Biological Products Recent Developments

11.7 Wuhan Keqian Biological Co., Ltd.

11.7.1 Wuhan Keqian Biological Co., Ltd. Company Information

11.7.2 Wuhan Keqian Biological Co., Ltd. Overview

11.7.3 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.7.4 Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 Wuhan Keqian Biological Co., Ltd. Recent Developments

11.8 China Biotechnology Co., Ltd.

11.8.1 China Biotechnology Co., Ltd. Company Information

11.8.2 China Biotechnology Co., Ltd. Overview

11.8.3 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.8.4 China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 China Biotechnology Co., Ltd. Recent Developments

11.9 CHINA ANIMAL HUSBANDRY INDUSTRY

11.9.1 CHINA ANIMAL HUSBANDRY INDUSTRY Company Information

11.9.2 CHINA ANIMAL HUSBANDRY INDUSTRY Overview

11.9.3 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.9.4 CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments

11.10 Sichuan Huashen

11.10.1 Sichuan Huashen Company Information

11.10.2 Sichuan Huashen Overview

11.10.3 Sichuan Huashen Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.10.4 Sichuan Huashen Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Sichuan Huashen Recent Developments

11.11 Haley

11.11.1 Haley Company Information

11.11.2 Haley Overview

11.11.3 Haley Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.11.4 Haley Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Haley Recent Developments

11.12 Tianbang

11.12.1 Tianbang Company Information

11.12.2 Tianbang Overview

11.12.3 Tianbang Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.12.4 Tianbang Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Tianbang Recent Developments

11.13 Dabei Nong

11.13.1 Dabei Nong Company Information

11.13.2 Dabei Nong Overview

11.13.3 Dabei Nong Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.13.4 Dabei Nong Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Dabei Nong Recent Developments

11.14 Harvey

11.14.1 Harvey Company Information

11.14.2 Harvey Overview

11.14.3 Harvey Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.14.4 Harvey Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 Harvey Recent Developments

11.15 Preh Bio

11.15.1 Preh Bio Company Information

11.15.2 Preh Bio Overview

11.15.3 Preh Bio Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.15.4 Preh Bio Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Preh Bio Recent Developments

11.16 Jiangsu Nannong High-Tech Co.

11.16.1 Jiangsu Nannong High-Tech Co. Company Information

11.16.2 Jiangsu Nannong High-Tech Co. Overview

11.16.3 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.16.4 Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Jiangsu Nannong High-Tech Co. Recent Developments

11.17 Guangxi Liyuan Biological Co., Ltd.

11.17.1 Guangxi Liyuan Biological Co., Ltd. Company Information

11.17.2 Guangxi Liyuan Biological Co., Ltd. Overview

11.17.3 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.17.4 Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.17.5 Guangxi Liyuan Biological Co., Ltd. Recent Developments

11.18 Jilin Zhengye Bioengineering Group

11.18.1 Jilin Zhengye Bioengineering Group Company Information

11.18.2 Jilin Zhengye Bioengineering Group Overview

11.18.3 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.18.4 Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.18.5 Jilin Zhengye Bioengineering Group Recent Developments

11.19 Jilin Heyuan Biological Engineering Co., Ltd.

11.19.1 Jilin Heyuan Biological Engineering Co., Ltd. Company Information

11.19.2 Jilin Heyuan Biological Engineering Co., Ltd. Overview

11.19.3 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.19.4 Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.19.5 Jilin Heyuan Biological Engineering Co., Ltd. Recent Developments

11.20 Huapai Biological Engineering Group Co., Ltd.

11.20.1 Huapai Biological Engineering Group Co., Ltd. Company Information

11.20.2 Huapai Biological Engineering Group Co., Ltd. Overview

11.20.3 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.20.4 Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.20.5 Huapai Biological Engineering Group Co., Ltd. Recent Developments

11.21 Beijing Xinde Weite Technology Co., Ltd.

11.21.1 Beijing Xinde Weite Technology Co., Ltd. Company Information

11.21.2 Beijing Xinde Weite Technology Co., Ltd. Overview

11.21.3 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.21.4 Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.21.5 Beijing Xinde Weite Technology Co., Ltd. Recent Developments

11.22 Beijing Veterinary Biopharmaceutical Factory

11.22.1 Beijing Veterinary Biopharmaceutical Factory Company Information

11.22.2 Beijing Veterinary Biopharmaceutical Factory Overview

11.22.3 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.22.4 Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.22.5 Beijing Veterinary Biopharmaceutical Factory Recent Developments

11.23 Qilu Animal Health Products Co., Ltd.

11.23.1 Qilu Animal Health Products Co., Ltd. Company Information

11.23.2 Qilu Animal Health Products Co., Ltd. Overview

11.23.3 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.23.4 Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.23.5 Qilu Animal Health Products Co., Ltd. Recent Developments

11.24 Shanxi Longkel Bio-Pharmaceutical Co., Ltd.

11.24.1 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Company Information

11.24.2 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Overview

11.24.3 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.24.4 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.24.5 Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Developments

11.25 Yunnan Biopharmaceutical Co.

11.25.1 Yunnan Biopharmaceutical Co. Company Information

11.25.2 Yunnan Biopharmaceutical Co. Overview

11.25.3 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.25.4 Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.25.5 Yunnan Biopharmaceutical Co. Recent Developments

11.26 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.

11.26.1 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Company Information

11.26.2 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Overview

11.26.3 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.26.4 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.26.5 Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Developments

11.27 Liaoning Yikang Biological Co., Ltd.

11.27.1 Liaoning Yikang Biological Co., Ltd. Company Information

11.27.2 Liaoning Yikang Biological Co., Ltd. Overview

11.27.3 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.27.4 Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.27.5 Liaoning Yikang Biological Co., Ltd. Recent Developments

11.28 Shanghui Huahong Biological Engineering Co., Ltd.

11.28.1 Shanghui Huahong Biological Engineering Co., Ltd. Company Information

11.28.2 Shanghui Huahong Biological Engineering Co., Ltd. Overview

11.28.3 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.28.4 Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.28.5 Shanghui Huahong Biological Engineering Co., Ltd. Recent Developments

11.29 Sichuan Hailinge Biological Pharmaceutical Co., Ltd.

11.29.1 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Company Information

11.29.2 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Overview

11.29.3 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.29.4 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.29.5 Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Developments

11.30 Guangdong Yongshun Biological Pharmaceutical Co., Ltd.

11.30.1 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Company Information

11.30.2 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Overview

11.30.3 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)

11.30.4 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

11.30.5 Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Pseudorabies Virus Vaccine Industry Chain Analysis

12.2 Pseudorabies Virus Vaccine Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Pseudorabies Virus Vaccine Production Mode & Process

12.4 Pseudorabies Virus Vaccine Sales and Marketing

12.4.1 Pseudorabies Virus Vaccine Sales Channels

12.4.2 Pseudorabies Virus Vaccine Distributors

12.5 Pseudorabies Virus Vaccine Customers

13 Market Dynamics

13.1 Pseudorabies Virus Vaccine Industry Trends

13.2 Pseudorabies Virus Vaccine Market Drivers

13.3 Pseudorabies Virus Vaccine Market Challenges

13.4 Pseudorabies Virus Vaccine Market Restraints

14 Key Findings in The Global Pseudorabies Virus Vaccine Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

Merck

Merial

Boehringer Ingelheim Animal Health (USA) Co., Ltd.

Zoetis Inc

Hipra

Wuhan Keqian Biological Co., Ltd.

China Biotechnology Co., Ltd.

CHINA ANIMAL HUSBANDRY INDUSTRY

Jiangsu Nannong High-Tech Co.

Guangxi Liyuan Biological Co., Ltd.

Jilin Zhengye Bioengineering Group

Jilin Heyuan Biological Engineering Co., Ltd.

Huapai Biological Engineering Group Co., Ltd.

Beijing Xinde Weite Technology Co., Ltd.

Beijing Veterinary Biopharmaceutical Factory

Qilu Animal Health Products Co., Ltd.

Shanxi Longkel Bio-Pharmaceutical Co., Ltd.

Yunnan Biopharmaceutical Co.

Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd.

Liaoning Yikang Biological Co., Ltd.

Shanghui Huahong Biological Engineering Co., Ltd.

Sichuan Hailinge Biological Pharmaceutical Co., Ltd.

Guangdong Yongshun Biological Pharmaceutical Co., Ltd.

List of Tables

Table 1. Global Pseudorabies Virus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Inactivated Vaccine

Table 3. Major Manufacturers of Naturally Deficient Attenuated Vaccine

Table 4. Major Manufacturers of Genetic Engineering Vaccine

Table 5. Global Pseudorabies Virus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Pseudorabies Virus Vaccine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 7. Global Pseudorabies Virus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 8. Global Pseudorabies Virus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 9. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2019-2024)

Table 10. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2025-2030)

Table 11. Global Pseudorabies Virus Vaccine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Pseudorabies Virus Vaccine Sales by Region (2019-2024) & (M Doses)

Table 13. Global Pseudorabies Virus Vaccine Sales by Region (2025-2030) & (M Doses)

Table 14. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2019-2024)

Table 15. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2025-2030)

Table 16. Global Pseudorabies Virus Vaccine Sales by Manufacturers (2019-2024) & (M Doses)

Table 17. Global Pseudorabies Virus Vaccine Sales Share by Manufacturers (2019-2024)

Table 18. Global Pseudorabies Virus Vaccine Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 19. Global Pseudorabies Virus Vaccine Revenue Share by Manufacturers (2019-2024)

Table 20. Global Key Players of Pseudorabies Virus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 21. Pseudorabies Virus Vaccine Price by Manufacturers 2019-2024 (USD/Doses)

Table 22. Global Pseudorabies Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 23. Global Pseudorabies Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pseudorabies Virus Vaccine as of 2023)

Table 24. Global Key Manufacturers of Pseudorabies Virus Vaccine, Manufacturing Base Distribution and Headquarters

Table 25. Global Key Manufacturers of Pseudorabies Virus Vaccine, Product Offered and Application

Table 26. Global Key Manufacturers of Pseudorabies Virus Vaccine, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 29. Global Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 30. Global Pseudorabies Virus Vaccine Sales Share by Type (2019-2024)

Table 31. Global Pseudorabies Virus Vaccine Sales Share by Type (2025-2030)

Table 32. Global Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 33. Global Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 34. Global Pseudorabies Virus Vaccine Revenue Share by Type (2019-2024)

Table 35. Global Pseudorabies Virus Vaccine Revenue Share by Type (2025-2030)

Table 36. Pseudorabies Virus Vaccine Price by Type (2019-2024) & (USD/Doses)

Table 37. Global Pseudorabies Virus Vaccine Price Forecast by Type (2025-2030) & (USD/Doses)

Table 38. Global Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 39. Global Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 40. Global Pseudorabies Virus Vaccine Sales Share by Application (2019-2024)

Table 41. Global Pseudorabies Virus Vaccine Sales Share by Application (2025-2030)

Table 42. Global Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 43. Global Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 44. Global Pseudorabies Virus Vaccine Revenue Share by Application (2019-2024)

Table 45. Global Pseudorabies Virus Vaccine Revenue Share by Application (2025-2030)

Table 46. Pseudorabies Virus Vaccine Price by Application (2019-2024) & (USD/Doses)

Table 47. Global Pseudorabies Virus Vaccine Price Forecast by Application (2025-2030) & (USD/Doses)

Table 48. US & Canada Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 49. US & Canada Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 50. US & Canada Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 51. US & Canada Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 52. US & Canada Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 53. US & Canada Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 54. US & Canada Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 55. US & Canada Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 56. US & Canada Pseudorabies Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 57. US & Canada Pseudorabies Virus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 58. US & Canada Pseudorabies Virus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 59. US & Canada Pseudorabies Virus Vaccine Sales by Country (2019-2024) & (M Doses)

Table 60. US & Canada Pseudorabies Virus Vaccine Sales by Country (2025-2030) & (M Doses)

Table 61. Europe Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 62. Europe Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 63. Europe Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 64. Europe Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 65. Europe Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 66. Europe Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 67. Europe Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 68. Europe Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 69. Europe Pseudorabies Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 70. Europe Pseudorabies Virus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 71. Europe Pseudorabies Virus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 72. Europe Pseudorabies Virus Vaccine Sales by Country (2019-2024) & (M Doses)

Table 73. Europe Pseudorabies Virus Vaccine Sales by Country (2025-2030) & (M Doses)

Table 74. China Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 75. China Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 76. China Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 77. China Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 78. China Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 79. China Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 80. China Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 81. China Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 82. Asia Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 83. Asia Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 84. Asia Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 85. Asia Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 86. Asia Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 87. Asia Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 88. Asia Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 89. Asia Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 90. Asia Pseudorabies Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 91. Asia Pseudorabies Virus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 92. Asia Pseudorabies Virus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 93. Asia Pseudorabies Virus Vaccine Sales by Region (2019-2024) & (M Doses)

Table 94. Asia Pseudorabies Virus Vaccine Sales by Region (2025-2030) & (M Doses)

Table 95. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Type (2019-2024) & (M Doses)

Table 96. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Type (2025-2030) & (M Doses)

Table 97. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Type (2019-2024) & (US$ Million)

Table 98. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Type (2025-2030) & (US$ Million)

Table 99. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Application (2019-2024) & (M Doses)

Table 100. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Application (2025-2030) & (M Doses)

Table 101. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Application (2019-2024) & (US$ Million)

Table 102. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Application (2025-2030) & (US$ Million)

Table 103. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 104. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 105. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 106. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Country (2019-2024) & (M Doses)

Table 107. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales by Country (2025-2030) & (M Doses)

Table 108. Merck Company Information

Table 109. Merck Description and Major Businesses

Table 110. Merck Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 111. Merck Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 112. Merck Recent Developments

Table 113. Merial Limited Company Information

Table 114. Merial Limited Description and Major Businesses

Table 115. Merial Limited Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 116. Merial Limited Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Merial Limited Recent Developments

Table 118. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Company Information

Table 119. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Description and Major Businesses

Table 120. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 121. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. Boehringer Ingelheim Animal Health (USA) Co., Ltd. Recent Developments

Table 123. Zoetis Company Information

Table 124. Zoetis Description and Major Businesses

Table 125. Zoetis Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 126. Zoetis Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Zoetis Recent Developments

Table 128. Hipra Company Information

Table 129. Hipra Description and Major Businesses

Table 130. Hipra Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 131. Hipra Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Hipra Recent Developments

Table 133. Anhui Divinity Biological Products Company Information

Table 134. Anhui Divinity Biological Products Description and Major Businesses

Table 135. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 136. Anhui Divinity Biological Products Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Anhui Divinity Biological Products Recent Developments

Table 138. Wuhan Keqian Biological Co., Ltd. Company Information

Table 139. Wuhan Keqian Biological Co., Ltd. Description and Major Businesses

Table 140. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 141. Wuhan Keqian Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Wuhan Keqian Biological Co., Ltd. Recent Developments

Table 143. China Biotechnology Co., Ltd. Company Information

Table 144. China Biotechnology Co., Ltd. Description and Major Businesses

Table 145. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 146. China Biotechnology Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. China Biotechnology Co., Ltd. Recent Developments

Table 148. CHINA ANIMAL HUSBANDRY INDUSTRY Company Information

Table 149. CHINA ANIMAL HUSBANDRY INDUSTRY Description and Major Businesses

Table 150. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 151. CHINA ANIMAL HUSBANDRY INDUSTRY Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. CHINA ANIMAL HUSBANDRY INDUSTRY Recent Developments

Table 153. Sichuan Huashen Company Information

Table 154. Sichuan Huashen Description and Major Businesses

Table 155. Sichuan Huashen Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 156. Sichuan Huashen Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. Sichuan Huashen Recent Developments

Table 158. Haley Company Information

Table 159. Haley Description and Major Businesses

Table 160. Haley Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 161. Haley Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. Haley Recent Developments

Table 163. Tianbang Company Information

Table 164. Tianbang Description and Major Businesses

Table 165. Tianbang Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 166. Tianbang Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. Tianbang Recent Developments

Table 168. Dabei Nong Company Information

Table 169. Dabei Nong Description and Major Businesses

Table 170. Dabei Nong Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 171. Dabei Nong Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 172. Dabei Nong Recent Developments

Table 173. Harvey Company Information

Table 174. Harvey Description and Major Businesses

Table 175. Harvey Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 176. Harvey Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 177. Harvey Recent Developments

Table 178. Preh Bio Company Information

Table 179. Preh Bio Description and Major Businesses

Table 180. Preh Bio Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 181. Preh Bio Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 182. Preh Bio Recent Developments

Table 183. Jiangsu Nannong High-Tech Co. Company Information

Table 184. Jiangsu Nannong High-Tech Co. Description and Major Businesses

Table 185. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 186. Jiangsu Nannong High-Tech Co. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 187. Jiangsu Nannong High-Tech Co. Recent Developments

Table 188. Guangxi Liyuan Biological Co., Ltd. Company Information

Table 189. Guangxi Liyuan Biological Co., Ltd. Description and Major Businesses

Table 190. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 191. Guangxi Liyuan Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 192. Guangxi Liyuan Biological Co., Ltd. Recent Developments

Table 193. Jilin Zhengye Bioengineering Group Company Information

Table 194. Jilin Zhengye Bioengineering Group Description and Major Businesses

Table 195. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 196. Jilin Zhengye Bioengineering Group Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 197. Jilin Zhengye Bioengineering Group Recent Developments

Table 198. Jilin Heyuan Biological Engineering Co., Ltd. Company Information

Table 199. Jilin Heyuan Biological Engineering Co., Ltd. Description and Major Businesses

Table 200. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 201. Jilin Heyuan Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 202. Jilin Heyuan Biological Engineering Co., Ltd. Recent Developments

Table 203. Huapai Biological Engineering Group Co., Ltd. Company Information

Table 204. Huapai Biological Engineering Group Co., Ltd. Description and Major Businesses

Table 205. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 206. Huapai Biological Engineering Group Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 207. Huapai Biological Engineering Group Co., Ltd. Recent Developments

Table 208. Beijing Xinde Weite Technology Co., Ltd. Company Information

Table 209. Beijing Xinde Weite Technology Co., Ltd. Description and Major Businesses

Table 210. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 211. Beijing Xinde Weite Technology Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 212. Beijing Xinde Weite Technology Co., Ltd. Recent Developments

Table 213. Beijing Veterinary Biopharmaceutical Factory Company Information

Table 214. Beijing Veterinary Biopharmaceutical Factory Description and Major Businesses

Table 215. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 216. Beijing Veterinary Biopharmaceutical Factory Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 217. Beijing Veterinary Biopharmaceutical Factory Recent Developments

Table 218. Qilu Animal Health Products Co., Ltd. Company Information

Table 219. Qilu Animal Health Products Co., Ltd. Description and Major Businesses

Table 220. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 221. Qilu Animal Health Products Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 222. Qilu Animal Health Products Co., Ltd. Recent Developments

Table 223. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Company Information

Table 224. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Description and Major Businesses

Table 225. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 226. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 227. Shanxi Longkel Bio-Pharmaceutical Co., Ltd. Recent Developments

Table 228. Yunnan Biopharmaceutical Co. Company Information

Table 229. Yunnan Biopharmaceutical Co. Description and Major Businesses

Table 230. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 231. Yunnan Biopharmaceutical Co. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 232. Yunnan Biopharmaceutical Co. Recent Developments

Table 233. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Company Information

Table 234. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Description and Major Businesses

Table 235. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 236. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 237. Jiujiang Bomeilai Biological Pharmaceutical Co., Ltd. Recent Developments

Table 238. Liaoning Yikang Biological Co., Ltd. Company Information

Table 239. Liaoning Yikang Biological Co., Ltd. Description and Major Businesses

Table 240. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 241. Liaoning Yikang Biological Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 242. Liaoning Yikang Biological Co., Ltd. Recent Developments

Table 243. Shanghui Huahong Biological Engineering Co., Ltd. Company Information

Table 244. Shanghui Huahong Biological Engineering Co., Ltd. Description and Major Businesses

Table 245. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 246. Shanghui Huahong Biological Engineering Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 247. Shanghui Huahong Biological Engineering Co., Ltd. Recent Developments

Table 248. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Company Information

Table 249. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Description and Major Businesses

Table 250. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 251. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 252. Sichuan Hailinge Biological Pharmaceutical Co., Ltd. Recent Developments

Table 253. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Company Information

Table 254. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Description and Major Businesses

Table 255. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)

Table 256. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Pseudorabies Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications

Table 257. Guangdong Yongshun Biological Pharmaceutical Co., Ltd. Recent Developments

Table 258. Key Raw Materials Lists

Table 259. Raw Materials Key Suppliers Lists

Table 260. Pseudorabies Virus Vaccine Distributors List

Table 261. Pseudorabies Virus Vaccine Customers List

Table 262. Pseudorabies Virus Vaccine Market Trends

Table 263. Pseudorabies Virus Vaccine Market Drivers

Table 264. Pseudorabies Virus Vaccine Market Challenges

Table 265. Pseudorabies Virus Vaccine Market Restraints

Table 266. Research Programs/Design for This Report

Table 267. Key Data Information from Secondary Sources

Table 268. Key Data Information from Primary Sources

List of Figures

Figure 1. Pseudorabies Virus Vaccine Product Picture

Figure 2. Global Pseudorabies Virus Vaccine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pseudorabies Virus Vaccine Market Share by Type in 2023 & 2030

Figure 4. Inactivated Vaccine Product Picture

Figure 5. Naturally Deficient Attenuated Vaccine Product Picture

Figure 6. Genetic Engineering Vaccine Product Picture

Figure 7. Global Pseudorabies Virus Vaccine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Pseudorabies Virus Vaccine Market Share by Application in 2023 & 2030

Figure 9. Government Tender

Figure 10. Market Sales

Figure 11. Pseudorabies Virus Vaccine Report Years Considered

Figure 12. Global Pseudorabies Virus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Pseudorabies Virus Vaccine Revenue 2019-2030 (US$ Million)

Figure 14. Global Pseudorabies Virus Vaccine Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 15. Global Pseudorabies Virus Vaccine Revenue Market Share by Region (2019-2030)

Figure 16. Global Pseudorabies Virus Vaccine Sales 2019-2030 ((M Doses)

Figure 17. Global Pseudorabies Virus Vaccine Sales Market Share by Region (2019-2030)

Figure 18. US & Canada Pseudorabies Virus Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 19. US & Canada Pseudorabies Virus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 20. Europe Pseudorabies Virus Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 21. Europe Pseudorabies Virus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 22. China Pseudorabies Virus Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 23. China Pseudorabies Virus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 24. Asia (excluding China) Pseudorabies Virus Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 25. Asia (excluding China) Pseudorabies Virus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Sales YoY (2019-2030) & (M Doses)

Figure 27. Middle East, Africa and Latin America Pseudorabies Virus Vaccine Revenue YoY (2019-2030) & (US$ Million)

Figure 28. The Pseudorabies Virus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 29. The Top 5 and 10 Largest Manufacturers of Pseudorabies Virus Vaccine in the World: Market Share by Pseudorabies Virus Vaccine Revenue in 2023

Figure 30. Global Pseudorabies Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 31. Global Pseudorabies Virus Vaccine Sales Market Share by Type (2019-2030)

Figure 32. Global Pseudorabies Virus Vaccine Revenue Market Share by Type (2019-2030)

Figure 33. Global Pseudorabies Virus Vaccine Sales Market Share by Application (2019-2030)

Figure 34. Global Pseudorabies Virus Vaccine Revenue Market Share by Application (2019-2030)

Figure 35. US & Canada Pseudorabies Virus Vaccine Sales Market Share by Type (2019-2030)

Figure 36. US & Canada Pseudorabies Virus Vaccine Revenue Market Share by Type (2019-2030)

Figure 37. US & Canada Pseudorabies Virus Vaccine Sales Market Share by Application (2019-2030)

Figure 38. US & Canada Pseudorabies Virus Vaccine Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Pseudorabies Virus Vaccine Revenue Share by Country (2019-2030)

Figure 40. US & Canada Pseudorabies Virus Vaccine Sales Share by Country (2019-2030)

Figure 41. U.S. Pseudorabies Virus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 42. Canada Pseudorabies Virus Vaccine Revenue (2019-2030) & (US$ Million)

Figure 43. Europe Pseudorabies Virus Vaccine Sales Market Share by Type (2019-2030)

Figure 44. Europe Pseudorabies Virus Vaccine Revenue Market Share by Type (2019-2030)

Figure 45. Europe Pseudorabies Virus Vaccine Sales Market Share by Application (2019-2030)

Figure 46. Europe Pseudorabies Virus Vaccine Revenue Market Share by Application (2019-2030)

Figure 47. Europe Pseudorabies Virus Vaccine Revenue Share by Country (2019-2030)

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions